Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-26

Clinical Trial Update: A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

View source ↗

Summary

A completed retrospective study evaluating anti-VEGF injections for retinal vein occlusion and diabetic macular edema with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-VEGF injections

Snippet

Sponsor: Allergan | Conditions: Retinal Vein Occlusion, Macular Edema | Status: COMPLETED | Results posted: 2016-05-26